Security key
00091F304
ABVC BIOPHARMA, INC. - Common Stock, par value $0.001 per share (ABVC)
CUSIP: 00091F304
Q3 2023 13F Holders as of 30 Sep 2023
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 76,762
- Total 13F value
- $79,757
- Share change
- +76,762
- SEC-reported price per share
- $1.04
- Number of holders
- 8
- Value change
- +$79,757
- Number of buys
- 8
- Shares outstanding
- 17,410,719
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2023
Institutions
8
Top holders
8
ABVC full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
ABVC BIOPHARMA, INC. SEC filings
ABVC BIOPHARMA, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00091F304
Recent filing periods:
Ownership snapshot
Top reported holders of ABVC - ABVC BIOPHARMA, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Shuling Jiang
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
0/15
Latest evidence
30 Jun 2023
3/4/5
13F
Highest disclosed value: $201,313
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
VANGUARD GROUP INC has the largest disclosed position value at $201.3K.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD GROUP INC's linked filing trail.
Disclosed position value
Top 5
VANGUARD GROUP INC
$201.3K
GEODE CAPITAL MANAGEMENT, LLC
$71K
TWO SIGMA INVESTMENTS, LP
$11.5K
NORTHERN TRUST CORP
$9.6K
Tower Research Capital LLC (TRC)
$7.2K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Shuling Jiang |
3/4/5
Director, 10%+ Owner
|
—
class O/S missing
|
—
7,908,805 shares
|
— | 20 May 2022 |
| VANGUARD GROUP INC |
13F
Company
|
—
class O/S missing
|
$201,313
387,513 shares
|
— | 30 Jun 2023 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
class O/S missing
|
$71,033
139,282 shares
|
— | 30 Jun 2023 |
| TWO SIGMA INVESTMENTS, LP |
13F
Company
|
—
class O/S missing
|
$11,481
22,101 shares
|
— | 30 Jun 2023 |
| NORTHERN TRUST CORP |
13F
Company
|
—
class O/S missing
|
$9,570
18,421 shares
|
— | 30 Jun 2023 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
—
class O/S missing
|
$7,217
13,879 shares
|
— | 30 Jun 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
8
Shares
76,762
Rows available
8
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
0
Q3 2023 holders
8
Holder diff
8
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 value | Q3 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend